Efficacy of Ofatumumab in Patients with Systemic Lupus Erythematosus who are allergic to Rituximab

Trial Profile

Efficacy of Ofatumumab in Patients with Systemic Lupus Erythematosus who are allergic to Rituximab

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Mar 2018

At a glance

  • Drugs Ofatumumab (Primary) ; Methylprednisolone
  • Indications Systemic lupus erythematosus
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Mar 2018 New trial record
    • 19 Mar 2018 Results (n=14) published in the Rheumatology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top